Asia IPOs: Private equity block

Getting into deals remains easier than getting out of them

Harley-Davidson: hog heaven

Group is pushing its bikes on new customers – and it is working

Valeant / Allergan: crow’s feet

A pharma deal with some wrinkles to smooth out to prolong the life of cash flows

GSK / Novartis: big renovation

Asset reshuffle should help both sides

Eli Lilly: animal spirits

Drugmaker has bought stability but diabetes is key to growth

Illustration by Raymond Biesinger of a compact disc
©Raymond Biesinger

Nidec: motoring along

Component maker’s shares have doubled in 12 months

AstraZeneca
©NewsCast

Pfizer / AstraZeneca: combination therapy

Commitment to diverse R&D clashes with cost savings objective

Arm Holdings: a leg up

Chip designer looks to power network equipment

ADP: commercial success

Payroll processing group knows which credit ratings matter

Cement makers: footprints

Case for letting Lafarge and Holcim merge is already at risk